Serum leptin levels in patients with chronic airway diseases Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005
Corticosteroid sensitivity in patients with chronic obstructive pulmonary disease is restored by theophylline Source: Annual Congress 2005 - Therapeutic options for COPD: present and future Year: 2005
IgE-autoantibodies and adipokines in patients with bronchial asthma and obesity Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012
Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002
Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015
Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Leptin, visfatin, insulin resistance, body composition change in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010
The effects of serum leptin on bone metabolism in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Plasma leptin in asthma patients with steroid induced diabetes compared with obesity patients Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007
Leptin in relation to systemic inflammation and regulation of the energy balance Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=56 Year: 2003
Leptin, adiponectin and ghrelin levels in female patients with asthma during stable and exacerbation periods Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012
Serum levels of circulating adipocytokines, leptin and adiponectin, in obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004
The influence of statin supplementation on inflammatory markers in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
Differences in levels of systemic inflammation markers between obese subjects with or without obstructive sleep apnea Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Pulmonary function and levels of serum leptin and interleukin-6 in women with bronchial asthma Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018
Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
Regulation of ghrelin on appetite in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation Source: Eur Respir J, 59 (2) 2100142; 10.1183/13993003.00142-2021 Year: 2022
Metabolic aspects of obstructive sleep apnoea syndrome Source: Eur Respir Rev 2009; 18: 113-124 Year: 2009